Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Accumulated Expenses (2019 - 2025)

AVITA Medical (RCEL) has disclosed Accumulated Expenses for 4 consecutive years, with $7.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses fell 25.24% year-over-year to $7.8 million, compared with a TTM value of $7.8 million through Dec 2025, down 25.24%, and an annual FY2025 reading of $7.8 million, down 25.24% over the prior year.
  • Accumulated Expenses was $7.8 million for Q4 2025 at AVITA Medical, up from $5.8 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $10.5 million in Q4 2024 and bottomed at $2.9 million in Q1 2022.
  • Average Accumulated Expenses over 4 years is $6.7 million, with a median of $6.9 million recorded in 2022.
  • The sharpest move saw Accumulated Expenses surged 58.34% in 2024, then plummeted 40.72% in 2025.
  • Year by year, Accumulated Expenses stood at $6.6 million in 2022, then rose by 20.37% to $8.0 million in 2023, then surged by 31.1% to $10.5 million in 2024, then decreased by 25.24% to $7.8 million in 2025.
  • Business Quant data shows Accumulated Expenses for RCEL at $7.8 million in Q4 2025, $5.8 million in Q3 2025, and $7.9 million in Q2 2025.